<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1187">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05145699</url>
  </required_header>
  <id_info>
    <org_study_id>B-2108-705-302</org_study_id>
    <nct_id>NCT05145699</nct_id>
  </id_info>
  <brief_title>A Pilot Study on the Feasibility Study of a Novel Virtual Reality (VR)-Based Post-stroke Hemineglect Evaluation System</brief_title>
  <official_title>A Pilot Study on the Feasibility Study of a Novel VR-based Post-stroke Hemineglect Evaluation System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The normal value of the new virtual reality (VR)-based hemineglect evaluation system is&#xD;
      obtained and its validity is checked by whether there is a difference in the evaluation&#xD;
      results between normal people, stroke patients with hemineglect, and stroke patients without&#xD;
      hemineglect. And, the usability of the virtual reality-based hemineglect evaluation system is&#xD;
      confirmed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study included 50 stroke patients with right hemisphere lesion and 25 healthy&#xD;
      people.&#xD;
&#xD;
      The normal value for each item is determined based on the result value for each item of the&#xD;
      virtual reality (VR)-based hemineglect evaluation system in normal people.&#xD;
&#xD;
      It is checked whether there is a difference in the results measured using the VR-based&#xD;
      hemineglect evaluation system in normal persons, stroke patients with hemineglect, and stroke&#xD;
      patients without hemineglect.&#xD;
&#xD;
      Structural validity is confirmed by examining the correlation between the measured values of&#xD;
      the virtual VR-based hemineglect evaluation system and Korean Version of Modified Barthel&#xD;
      Index (K-MBI), Mini Mental State Examination (MMSE), and Behavioral Inattention&#xD;
      Test-Conventional (BIT-C) in stroke patients with hemineglect.&#xD;
&#xD;
      Check the required time and test stability of the evaluation using the VR-based hemineglect&#xD;
      evaluation system.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 31, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>8 items of virtual reality-based hemineglect evaluation system</measure>
    <time_frame>up to 1 year</time_frame>
    <description>(1)Visual extinction, (2)Visual tracking, (3-6)Visual scanning, (7)Auditory, (8)Activities of Daily Living (ADL)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Stroke, Complication</condition>
  <arm_group>
    <arm_group_label>Right hemispheric stroke with hemineglect</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Right hemispheric stroke without hemineglect</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal people</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VR-based post-stroke hemineglect evaluation system</intervention_name>
    <description>Evaluation system applied with virtual environment using Pico Neo 2 eye</description>
    <arm_group_label>Normal people</arm_group_label>
    <arm_group_label>Right hemispheric stroke with hemineglect</arm_group_label>
    <arm_group_label>Right hemispheric stroke without hemineglect</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        (Stroke patients)&#xD;
&#xD;
          -  Right handed&#xD;
&#xD;
          -  Patients with first onset stroke, with right brain lesions confirmed by imaging tests&#xD;
             (MRI, CT)&#xD;
&#xD;
          -  Onset of stroke more than 1week (Normal people)&#xD;
&#xD;
          -  Right handed&#xD;
&#xD;
          -  Who has no problem in identifying objects with wearing VR head gear.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        (Stroke patients)&#xD;
&#xD;
          -  Patients with unilateral neglect due to other causes.&#xD;
&#xD;
          -  Patients with neurological diseases other than stroke (Parkinson's disease,&#xD;
             Alzheimer's disease, etc.)&#xD;
&#xD;
          -  Patients with severe cognitive impairment.&#xD;
&#xD;
          -  Patients with underlying diseases or medical history that may cause visual impairment.&#xD;
&#xD;
        (Normal people)&#xD;
&#xD;
          -  Who has a neurological disease such as stroke, traumatic brain injury, Parkinson's&#xD;
             disease, or Alzheimer's disease.&#xD;
&#xD;
          -  Who has a severe cognitive impairment.&#xD;
&#xD;
          -  Who has a underlying diseases or medical history that may cause visual impairment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nam-Jong Paik, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital, Seongnam, South Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nam-Jong Paik, Ph.D</last_name>
    <phone>82-31-787-7731</phone>
    <email>njpaik@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nam-Jong Paik, MD, PhD</last_name>
      <phone>82-031-787-7731</phone>
      <email>njpaik@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>November 22, 2021</last_update_submitted>
  <last_update_submitted_qc>November 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

